JIC
ASXC

Joel Isaacson & Co’s Asensus Surgical, Inc. ASXC Stock Holding History

Joel Isaacson & Co’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-385
Closed -$15K – 781
2015
Q2 		$15K Buy
+385
New +$17.7K ﹤0.01% 543

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Joel Isaacson & Co's ASXC Position: Q3 2015 in Review

Joel Isaacson & Co sold out of Asensus Surgical, Inc. (ASXC) in Q3 2015, closing a stake of 385 shares — an estimated $15K sold.

Joel Isaacson & Co first reported a position in ASXC in Q2 2015 and held it in 1 quarter. The position peaked at $15K in Q2 2015. 67 funds tracked by Wall St. Rank hold ASXC as of Q3 2015.

  • Joel Isaacson & Co reported no remaining Asensus Surgical, Inc. position as of Q3 2015 after selling out during the quarter.
  • Joel Isaacson & Co sold 385 Asensus Surgical, Inc. shares in Q3 2015, an estimated $15K.
  • Joel Isaacson & Co first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 1 quarter.
  • Joel Isaacson & Co's Asensus Surgical, Inc. position peaked at $15K in Q2 2015.
  • 67 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2015.

Based on Joel Isaacson & Co's 13F filing for Q3 2015, filed 21 Oct 2015.